NEXN-AS1

Model summary

A soluble human scaffold that promotes programmed cell death by organizing nucleoplasmic protein assemblies that commit cells to apoptosis. Lacking catalytic motifs, it functions through multivalent binding to assemble and stabilize apoptotic signaling complexes, thereby tuning initiator and executioner pathways. Its nucleoplasmic residence positions it to integrate nuclear stress cues with extrinsic pathway inputs and to drive orderly progression toward cell-fate execution.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The sequence carries a single annotated module: GO:0005515 protein binding. The presence of only a generic protein-binding signature and no catalytic or transmembrane domains indicates a soluble adaptor or scaffold rather than an enzyme or transporter. Such architectures typically mediate regulated assembly of signaling complexes through multivalent interactions.

2. 02

   From this binding-centric core, the most direct molecular function is protein binding (GO:0005515).

   A non-enzymatic scaffold that concentrates partners in signaling pathways often dictates cell-fate decisions by controlling the stoichiometry and timing of complex formation. This causal role aligns with apoptosis control: by assembling and stabilizing pro- or anti-apoptotic assemblies, the protein can bias the pathway toward programmed cell death. That logic supports the biological process of apoptotic process (GO:0006915), where scaffolded complexes tune initiator and executioner pathways.

3. 03

   Cellular placement follows from the soluble adaptor nature and the need to coordinate transcriptional and signaling hubs.

   The absence of membrane features and the frequent coupling of apoptotic regulators to nuclear signaling argue for a nuclear interior locale. A nucleoplasmic residence (GO:0005654 nucleoplasm) enables the protein to interface with chromatin-associated factors and nuclear stress bodies that orchestrate apoptotic gene expression and checkpoint control. This nucleoplasmic positioning also rationalizes how a binding scaffold can rapidly relay cues between nuclear stress signaling and cytoplasmic apoptotic machinery.

4. 04

   Mechanistically, a nucleoplasmic scaffold that binds partners can nucleate higher-order assemblies that commit cells to apoptosis.

   It likely captures adaptors and effectors of the extrinsic pathway—such as death receptor-proximal adaptors—and bridges to mitochondrial amplification modules. By concentrating these factors in the nucleus and at nuclear peripheries, the protein can accelerate pathway commitment while buffering spurious activation.

5. 05

   This model predicts interaction partners that are central to apoptotic decision-making and complex assembly: extrinsic-pathway adaptors and modulators (e.g., FADD and CFLAR), initiator proteases and their regulators (e.g., caspase-8 and CFLAR), and nucleoplasmic hubs that coordinate stress responses.

   Together, these interactions would allow the scaffold to tune apoptotic thresholds through spatial organization rather than catalysis.